QC-Based Procurement Workflow

Pharmaceutical manufacturing depends on raw materials, packaging components, and consumables that meet defined quality standards before they ever reach a production line. An Erpnext QC-Based Procurement Workflow ensures that no purchased material moves into stores or manufacturing until it has been sampled, tested, and formally released by the Quality Control department. This feature connects procurement, warehouse, and QC functions inside SigzenPHARMA into a single controlled process, replacing manual coordination between departments with a system-driven checkpoint. This workflow is used at the point of goods receipt, where incoming raw materials, active pharmaceutical ingredients (APIs), excipients, and packaging materials must be quarantined and tested before use. By enforcing QC approval as a mandatory step, SigzenPHARMA helps pharmaceutical manufacturers prevent unauthorized use of untested materials, maintain GMP compliance, and build a defensible, auditable record of every procurement-to-release decision.

Material Receipt and Automatic Quarantine

When a purchased item is received against a purchase order, SigzenPHARMA does not allow it to move directly into usable inventory. Instead, the system places the received quantity into a quarantine location automatically.

  • System-Enforced Quarantine Status Every incoming lot is tagged as Under Test the moment it is received, preventing production or warehouse staff from issuing it accidentally.
  • Batch and Vendor Linking Each received lot is linked to its purchase order, vendor, invoice, and vendor batch number, so the material's origin is traceable from the first entry.
  • Storage Segregation Quarantined stock is mapped to a distinct warehouse or storage bin, keeping it physically and systemically separate from released materials.

QC Sampling and Test Assignment

Once material is quarantined, SigzenPHARMA generates a sampling request for the QC team based on predefined sampling plans tied to the item or material category.

How Sampling Requests Work

  • The system identifies the applicable specification  linked to the item master.
  • A sampling quantity is suggested based on AQL tables or organization-defined sampling rules.
  • QC analysts receive an assigned task listing the tests required identification, assay, microbial limits, physical characteristics, or other parameters specific to the material.

This removes dependency on verbal communication between stores and QC, since the test requirement is generated directly from the received transaction.

Test Result Entry and Specification Comparison

QC personnel record test results directly against the assigned specification inside SigzenPHARMA. The system compares each recorded value against the approved acceptance range for that parameter.

  • Automated Pass/Fail Evaluation Results outside the specification limits are flagged automatically, reducing dependence on manual cross-checking of numbers against paper specifications.
  • Multi-Parameter Test Recording Materials requiring several tests — such as loss on drying, pH, particle size, or heavy metals are recorded against a single lot record rather than scattered logs.
  • Reviewer Sign-Off A second-level reviewer or QC supervisor confirms the entered data before it proceeds to disposition, supporting a two-person verification approach common in GMP labs.

Disposition Decision and Release Approval

Based on test outcomes, the QC-Based Procurement Workflow routes the lot to one of three disposition paths: Approved, Rejected, or Under Review .

  • Approved Lots are automatically released from quarantine into usable inventory, becoming visible to production planning and material issue functions.
  • Rejected Lots are blocked from further movement, and the system prompts a rejection reason, vendor notification, and return or destruction workflow.
  • Under Review Lots such as out-of-specification (OOS) results trigger a hold status until an investigation is documented and closed, preventing premature release.

This structured disposition step ensures no material bypasses a genuine quality decision, even when production schedules are tight.

Vendor and Batch-Level Traceability

Because every procurement transaction is linked to its QC outcome, SigzenPHARMA builds a continuous traceability chain from vendor to finished batch.

  • Vendor Quality History Rejection rates, recurring OOS results, and delayed testing patterns are visible against each vendor, supporting supplier qualification and periodic vendor review.
  • Forward and Backward Traceability A finished product batch can be traced back to the specific raw material lot, test results, and approving QC analyst; conversely, a raw material lot can be traced forward to every batch it was used in.
  • Recall Readiness If a vendor lot is later found non-compliant, all batches that consumed material from that lot can be identified quickly for assessment or recall action.

Approval Workflow and Role-Based Access

The workflow enforces separation of duties between procurement, warehouse, and quality functions.

  • Role-Based Task Routing Only authorized QC users can update test results or approve disposition; purchase and store users can view status but cannot override it.
  • Escalation for Pending Reviews Lots pending disposition beyond a defined time are flagged to QC supervisors, preventing indefinite quarantine holding.
  • Electronic Approval Records Each approval or rejection is captured with user ID, date, and time, forming part of the batch documentation package.

Audit Trail and Documentation Support

Every stage of the QC-Based Procurement Workflow receipt, quarantine, sampling, testing, disposition, and release is logged with a timestamp and user identity.

  • Complete Audit Trail Every action, review, and approval is recorded for inspection readiness, supporting responses during regulatory audits or customer quality audits.
  • Deviation Linkage OOS or rejected lots can be linked directly to a deviation or CAPA record for further investigation, keeping quality records connected rather than isolated.
  • Retrievable Certificates of Analysis QC-generated results can be compiled into a Certificate of Analysis (CoA) format for internal records or vendor communication.

Frequently Asked Questions

What is Erpnext QC-Based Procurement Workflow in pharmaceutical manufacturing?

It is a system-controlled process within SigzenPHARMA that requires every incoming raw material, API, or packaging component to pass QC testing and formal disposition before it can be used in production or dispatched from stores.

How does QC-Based Procurement Workflow improve process control?

It removes manual handoffs between purchase, stores, and QC teams by automatically quarantining received material, generating test assignments, and blocking movement of unapproved lots until a disposition decision is recorded.

How does this feature support GMP compliance?

GMP requires that materials be tested and released before use. This workflow enforces that requirement systemically, so materials cannot bypass quarantine or be issued without a recorded QC approval, supporting compliance with quality system regulations.

Can QC-Based Procurement Workflow improve documentation accuracy?

Yes. Test results, specifications, disposition decisions, and approvals are recorded directly in the system against the specific lot, reducing transcription errors that occur when data is transferred from paper logs to records manually.

How does this feature help during audits?

Auditors can trace any raw material lot from receipt through testing to disposition and final batch usage in a single review, since all actions carry timestamps and user identity, reducing the time needed to compile documentation during inspections.

Which departments typically use this feature?

Purchase, Warehouse/Stores, and Quality Control departments use this workflow directly, while Production and Regulatory Affairs rely on its output — released material status and traceability data — for planning and compliance reporting.

What happens if a material fails QC testing?

The lot is marked rejected within the system, blocked from issue, and routed into a vendor return or destruction process, with the rejection reason and QC decision retained as part of the material's record.

Does this workflow support retesting or stability-related holds?

Yes. Materials pending retest, additional investigation, or extended stability review are held in an Under Review status, preventing release until the additional evaluation is documented and closed.

Conclusion

The Erpnext QC-Based Procurement Workflow in SigzenPHARMA connects procurement activity directly to quality decision-making, ensuring that raw materials, APIs, and packaging components are tested and formally released before entering production. By automating quarantine, sampling assignment, specification comparison, and disposition, the feature reduces reliance on manual coordination while strengthening documentation accuracy. Vendor-linked traceability, role-based approvals, and a complete audit trail give pharmaceutical manufacturers a dependable structure for GMP compliance and audit readiness, making material release a controlled, verifiable step rather than an informal checkpoint.